Want to join the conversation?
Medical solutions provider $BSX announced 3Q15 sales of $1.888Bil compared to its guidance of $1.790-1.840Bil, representing an increase of 2% in operational revenue growth on a reported basis. This performance was driven by strong sales and differentiated adjusted operating margin expansion. $BSX also reported a GAAP loss of $0.15 per share.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.